Literature DB >> 19838289

Role of Placebo Factors in Clinical Trials with Special Focus on Enrichment Designs.

Roland Staud1, Donald D Price.   

Abstract

Entities:  

Year:  2008        PMID： 19838289      PMCID： PMC2577080          DOI： 10.1016/j.pain.2008.07.027

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  7 in total

1.  A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia.

Authors:  Lene Vase; Joseph L Riley; Donald D Price
Journal:  Pain       Date:  2002-10       Impact factor: 6.961

Review 2.  A comprehensive review of the placebo effect: recent advances and current thought.

Authors:  Donald D Price; Damien G Finniss; Fabrizio Benedetti
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

3.  Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.

Authors:  Leslie J Crofford; Michael C Rowbotham; Philip J Mease; I Jon Russell; Robert H Dworkin; Ann E Corbin; James P Young; Linda K LaMoreaux; Susan A Martin; Uma Sharma
Journal:  Arthritis Rheum       Date:  2005-04

Review 4.  Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review.

Authors:  Sebastian Straube; Sheena Derry; Henry J McQuay; R Andrew Moore
Journal:  Br J Clin Pharmacol       Date:  2008-04-11       Impact factor: 4.335

5.  Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors.

Authors:  Roland Staud; Donald D Price
Journal:  Pain       Date:  2008-04-01       Impact factor: 6.961

6.  The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation.

Authors:  Lene Vase; Michael E Robinson; G Nicholas Verne; Donald D Price
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

7.  Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.

Authors:  Leslie J Crofford; Philip J Mease; Susan L Simpson; James P Young; Susan A Martin; George M Haig; Uma Sharma
Journal:  Pain       Date:  2008-04-08       Impact factor: 6.961
  7 in total
  2 in total

1.  The Placebo Effect in Pain Therapies.

Authors:  Luana Colloca
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-09-14       Impact factor: 13.820

Review 2.  Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids.

Authors:  Barth Wilsey; Reena Deutsch; Thomas D Marcotte
Journal:  Cannabis Cannabinoid Res       Date:  2016-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.